performed a cross-trial analysis using data from clinical trials of GLP-1RAs (ELIXA, LEADER, SUSTAIN-6, EXSCEL, HARMONY, REWIND, PIONEER-6 [59], and AMPLITUDE-O), SGLT2is (CANVAS and CREDENCE), and finerenone (FIDELIO-DKD and FIGARO-DKD) to estimate the effects of the triple combination therapy of GLP-1RA, SGLT2i, and finerenone using the actuarial method [60]
We know this from everyday life
Standardization of methodologies across studies will also be essential to improve reproducibility and comparability
Confirmation of identity and verification of purity for each component lot are essential, since an under-dosed, degraded or copper-depleted preparation will distort results